To include your compound in the COVID-19 Resource Center, submit it here.

Novavax reports Phase I/II data for influenza vaccine NanoFlu

Novavax Inc. (NASDAQ:NVAX) reported top-line data from a U.S. Phase I/II

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE